Grown Rogue International (GRUSF) Capital Expenditures Growth (5y) (2023)
Grown Rogue International (GRUSF) Capital Expenditures Growth (5y) (2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 92.25 Bn | 90.38 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.33 Bn | 32.59 Bn | 1.97 Bn |
| 3 | Zoetis | 32.84 Bn | 30.89 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.75 Bn | 20.60 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.75 Bn | 22.75 Bn | - |
| 7 | Viatris | 20.60 Bn | 18.79 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 18.31 Bn | 16.99 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.73 Bn | 12.30 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.42 Mn | 85.71 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | -22.74% |
| Jul 31, 2023 | -51.85% |
| Apr 30, 2023 | -23.87% |
| Jan 31, 2023 | 44.96% |